Clik here to view.
Fresenius Medical Care launches new mobile app to empower and engage nurses
HONG KONG Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced the launch of Carrie, a custom-built mobile app that...
View ArticleClik here to view.
Fresenius Medical Care Asia Pacific Receives Prestigious ACHS Global Quality...
HONG KONG Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, was presented with the prestigious Australian Council for Healthcare...
View ArticleClik here to view.
Chinese Enterprise By-Health Launches the World’s First Personalized...
ZHUHAI, China On December 19th, By-Health took the lead in launching the first personalized customized vitamin concept product at the conference of “Definition of Nutrition Intelligence”, which...
View ArticleClik here to view.
TandemAI Announces $25 Million Seed ＆ Pre-series A Financing Led by OrbiMed...
SUZHOU, China & SHANGHAI TandemAI today announced it has raised $25 million in Seed and pre-Series A financing to advance its proprietary computational platform and expansion of its wet lab...
View ArticleClik here to view.
Curia Unveils Comprehensive mRNA Solution
ALBANY, N.Y. Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA (mRNA) solution, which includes discovery, process...
View ArticleClik here to view.
DESTINY-Lung04 Phase 3 Trial of ENHERTU® Initiated in Patients with...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the first patient was dosed in the global DESTINY-Lung04 phase 3 trial...
View ArticleClik here to view.
Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1...
BROOKLYN, N.Y. Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, today announced that the U.S. Food and Drug Administration...
View ArticleClik here to view.
Accutar Biotechnology、前立腺がんを対象としたAC0176の第1相臨床試験のIND申請をFDAが承認したと発表
米ニューヨーク州ブルックリン （ビジネスワイヤ） — 人工知能（AI）の力を活用した創薬に傾注するバイオテクノロジー企業のAccutar Biotechnology,...
View ArticleClik here to view.
Accutar Biotechnology宣布FDA批准AC0176用于治疗前列腺癌的1期试验的IND申请
纽约布鲁克林 (美国商业资讯)–专注于利用人工智能(AI)赋能药物发现的生物技术公司Accutar Biotechnology, Inc.今天宣布，美国食品药品管理局(FDA)已批准该公司在研新药AC0176用于治疗转移性去势难治性前列腺癌(mCRPC)患者的试验用新药申请(IND)。AC0176是一种口服生物可利用(orally...
View ArticleClik here to view.
Bio-Thera Solutions Announces Initiation of Phase I Clinical Trials for...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase I clinical study to compare the pharmacokinetics...
View ArticleClik here to view.
CORRECTING and REPLACING Chinese Enterprise By-Health Launches the First...
ZHUHAI, China Please replace the release dated December 22, 2021 with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here:...
View ArticleClik here to view.
Babson Graduate Pooja Ika Launches eternalHealth, the First New Medicare...
BOSTON eternalHealth, the first new health plan to be approved in Massachusetts since 2013, has officially announced its launch of the company, delivering high-quality and affordable Medicare...
View ArticleClik here to view.
HighTide Therapeutics Appoints Jin Chen, Ph.D., as SVP DMPK and Clinical...
SHENZHEN, China & ROCKVILLE, Md. HighTide Therapeutics Inc., a clinical-stage biopharmaceutical company developing treatments for liver diseases, gastrointestinal diseases and metabolic...
View ArticleClik here to view.
New Frontier Health Corporation Announces Shareholders’ Approval of Merger...
BEIJING New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that, at an extraordinary...
View ArticleClik here to view.
Pharmaron Appoints Dr. Sid Bhoopathy as Senior Vice President, US Head of...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) today announced the appointment of Dr. Sid Bhoopathy as Senior Vice President, US Head of Laboratory Services and...
View ArticleClik here to view.
Pharmaron Acquires Commercial API Manufacturing Facility in the United...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from Recipharm...
View ArticleClik here to view.
Clik here to view.
Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and...
NEW YORK & LONDON & PARIS Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces...
View ArticleClik here to view.
Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today confirmed the company is positioned for growth in the mid- and long-term with the...
View ArticleClik here to view.
The World Must Challenge China’s Attack on Public Health Transparency, Says AHF
LOS ANGELES AIDS Healthcare Foundation (AHF) expressed alarm and disappointment today over China’s reported move to delete language supporting rapid World Health Organization (WHO) access to...
View Article